SARS-CoV-2 Circulation in the School Setting: A Systematic Review and Meta-Analysis

The contribution of children to viral spread in schools is still debated. We conducted a systematic review and meta-analysis of studies to investigate SARS-CoV-2 transmission in the school setting. Literature searches on 15 May 2021 yielded a total of 1088 publications, including screening, contact...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of environmental research and public health Vol. 19; no. 9; p. 5384
Main Authors Caini, Saverio, Martinoli, Chiara, La Vecchia, Carlo, Raimondi, Sara, Bellerba, Federica, D'Ecclesiis, Oriana, Sasso, Clementina, Basso, Alessandra, Cammarata, Giulio, Gandini, Sara
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 28.04.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The contribution of children to viral spread in schools is still debated. We conducted a systematic review and meta-analysis of studies to investigate SARS-CoV-2 transmission in the school setting. Literature searches on 15 May 2021 yielded a total of 1088 publications, including screening, contact tracing, and seroprevalence studies. MOOSE guidelines were followed, and data were analyzed using random-effects models. From screening studies involving more than 120,000 subjects, we estimated 0.31% (95% confidence interval (CI) 0.05-0.81) SARS-CoV-2 point prevalence in schools. Contact tracing studies, involving a total of 112,622 contacts of children and adults, showed that onward viral transmission was limited (2.54%, 95% CI 0.76-5.31). Young index cases were found to be 74% significantly less likely than adults to favor viral spread (odds ratio (OR) 0.26, 95% CI 0.11-0.63) and less susceptible to infection (OR 0.60; 95% CI 0.25-1.47). Lastly, from seroprevalence studies, with a total of 17,879 subjects involved, we estimated that children were 43% significantly less likely than adults to test positive for antibodies (OR 0.57, 95% CI 0.49-0.68). These findings may not applied to the Omicron phase, we further planned a randomized controlled trial to verify these results.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Review-1
ObjectType-Article-3
ObjectType-Undefined-4
ISSN:1660-4601
1661-7827
1660-4601
DOI:10.3390/ijerph19095384